234 F. Supp. 3d 873
W.D. Ky.2017Background
- Decedent Jerry DeMoss began taking Effient (prasugrel) in April 2014 and died of a massive cerebral hemorrhage in July 2014; plaintiffs sued Eli Lilly two years later claiming Effient caused the death.
- Effient was FDA‑approved in July 2009 based largely on the TRITON‑TIMI 38 trial showing greater ischemic protection than clopidogrel but a significantly higher bleeding risk, including fatal bleeding.
- Plaintiffs allege Lilly marketed Effient as superior to alternatives (e.g., Plavix), failed adequately to disclose the increased, irreversible bleeding risk and suppressed safety concerns (including removal of an FDA panelist).
- Complaint asserts: strict products liability (design, manufacturing, failure to warn), negligence (design, manufacturing, failure to warn), breach of implied warranty, negligent misrepresentation, KCPA violation, and loss of consortium.
- Lilly moved to dismiss under Fed. R. Civ. P. 8(a), 9(b), and 12(b)(6); the court applied Iqbal/Twombly pleading standards and Kentucky product‑liability law (including Restatement §402A comment k).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Strict‑liability — design defect (comment k) | Effient’s design created unreasonably high, irreversible bleeding risk versus alternatives; benefits did not outweigh risks. | FDA approval and comment k immunize against design‑defect liability; complaint is conclusory about the design defect. | Denied dismissal. Comment k analysis is fact‑dependent and plaintiffs pleaded plausible allegations that Effient’s risk/absence of reversal rendered it defective. |
| Strict‑liability — manufacturing defect | Alleged generally that Effient was defectively manufactured. | Claim is conclusory; no specific facts showing a manufacturing deviation from specs. | Granted dismissal without prejudice for failure to plead specific manufacturing defect. |
| Failure to warn (strict liability and negligence) | Lilly failed to warn prescribers/patients of known or knowable life‑threatening bleeding risk and lack of reversal, and failed to adequately study/signal the risk. | Warnings adequate; plaintiffs’ allegations are conclusory. | Denied dismissal. Complaint sufficiently alleges inadequate warnings and causation under Kentucky standards. |
| Negligent misrepresentation | Promotional materials misrepresented safety/benefit and omitted material safety information to DeMoss and his clinicians. | Claim improper in product‑liability context and pleadings fail to identify affirmative misrepresentations with required particularity. | Granted dismissal without prejudice. Kentucky requires an affirmative false statement; plaintiffs alleged omissions, not an identified affirmative misrepresentation, and failed Rule 9(b) particularity. |
| Breach of implied warranty & KCPA | Plaintiffs argue Lilly made direct representations and thus privity exception applies. | No privity; no express warranties alleged that run to consumer; KCPA requires buyer/lessee status absent express warranty. | Both claims dismissed without prejudice for failure to plead privity/express warranty facts. |
| Negligent design & negligent failure to warn | Negligence claims parallel strict liability and are permitted as alternative theories. | — | Denied dismissal for negligent design and negligent failure to warn; negligent manufacturing claim dismissed without prejudice for lack of specific factual allegations. |
Key Cases Cited
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard: plausible factual allegations required)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility and dismissal standard; more than labels and conclusions required)
- Prather v. Abbott Labs., 960 F. Supp. 2d 700 (W.D. Ky. 2013) (discusses application of Restatement comment k and failure‑to‑warn in pharma cases)
- Bosch v. Bayer Healthcare Pharms., Inc., 13 F. Supp. 3d 730 (W.D. Ky. 2014) (analyzing implied warranty/privity and pleading requirements in drug‑injury suits)
- Giddings & Lewis, Inc. v. Industrial Risk Insurers, 348 S.W.3d 729 (Ky. 2011) (Kentucky discusses Restatement (Third) §9 and negligent misrepresentation; omission vs. affirmative misstatement distinction)